Study Published in Journal of Antimicrobial Stewardship Shows Patients Diagnosed with T2Candida Panel Treated More Than Eight Times Faster
Patients tested with the T2 Magnetic Resonance (T2MR) platform were treated in a median of 5 hours, a more than 8-fold reduction as compared to that based on blood culture, which delayed appropriate therapy by a median of 44 hours. This speed advantage demonstrates that the T2MR platform is a valuable clinical tool to aid antifungal stewardship’s goal to deliver timely antifungal therapy for infected patients.
